Attention-deficit hyperactivity disorder epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}} {{AE}} {{KS}}, {{HW}}
{{CMG}}; {{AE}} {{KS}}, {{HW}}


{{ADHD}}
{{ADHD}}

Revision as of 18:34, 11 August 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2], Haleigh Williams, B.S.

Attention-deficit hyperactivity disorder Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Attention-Deficit Hyperactivity Disorder from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Psychiatric Examination

Laboratory Findings

Imaging Findings

Treatment

Medical Therapy

Psychotherapy

Brain Stimulation Therapy

Cost-Effectiveness of Therapy

Monitoring Response to Therapy

Future or Investigational Therapies

Case Studies

Case #1

Template:Attention-deficit hyperactivity disorder On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Attention-deficit hyperactivity disorder epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Attention-deficit hyperactivity disorder epidemiology and demographics

CDC on Attention-deficit hyperactivity disorder epidemiology and demographics

Attention-deficit hyperactivity disorder epidemiology and demographics in the news

Blogs on Attention-deficit hyperactivity disorder epidemiology and demographics

Directions to Hospitals Treating Attention-deficit hyperactivity disorder

Risk calculators and risk factors for Attention-deficit hyperactivity disorder epidemiology and demographics

Overview

The prevalence of attention-deficit hyperactivity disorder (ADHD) is estimated to be 5,000 per 100,000 (5%) children and 2,500 per 100,000 (2.5%) adults.[1] Boys are more commonly affected by ADHD than girls. The male to female ratio is 2 to 1.[2]

Epidemiology and Demographics

Prevalence

  • The prevalence of ADHD in children is 5,000 per 100,000 (5%) of the overall population.[1]
  • The prevalence of ADHD in adults is 2,500 per 100,000 (2.5%) of the overall population.[1]

Incidence

Based on the Health Resources and Services Administration's National Survey of Children's Health, the percentage of children age 4-17 years diagnosed with ADHD increased from 7.8 percent in 2003 to 9.5 percent in 2007. [3]

Age

  • ADHD is usually first diagnosed in school-aged children. For an adult to be diagnosed with ADHD, the patient’s symptoms must have been present prior to the age of 12.[4]

Gender

  • ADHD is more prevalent in males than in females. The male to female ratio is approximately 2 to 1.[2]

Race

  • ADHD is observed in patients of all racial/ethnic backgrounds, but does appear to be most common in non-Hispanic Caucasians.[2]

References

  1. 1.0 1.1 1.2 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
  2. 2.0 2.1 2.2 Briars, L., & Todd, T. (2016). A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. The Journal of Pediatric Pharmacology and Therapeutics : JPPT, 21(3), 192–206. http://doi.org/10.5863/1551-6776-21.3.192.
  3. Zuvekas SH, Vitiello B (2012). "Stimulant medication use in children: a 12-year perspective". Am J Psychiatry. 169 (2): 160–6. doi:10.1176/appi.ajp.2011.11030387. PMC 3548321. PMID 22420039.
  4. National Institute of Mental Health (NIH). (2016). "Attention Deficit Hyperactivity Disorder."

Template:WH Template:WS